In a new job - May 5, 2025
Leadership changes at deCODE genetics
The tenure of Kari Stefánsson, founder and CEO of deCODE genetics, has come to an end and the company has appointed two co-managing directors during the transition.
In a new job - May 2, 2025
Resitu appoints new Chief Executive Officer
Resitu has appointed Åsa Runnäs as the company’s CEO, building on her 20 years of experience in device regulation and commercialization.
In a new job - April 24, 2025
She is the new CEO of Hansa Biopharma
Hansa Biopharma has announced the appointment of Renée Aguiar-Lucander as Chief Executive Officer (CEO), effective immediately.
Biotech Business - April 15, 2025
Nykode’s CEO, CSO and CFO have withdrawn their resignations
Nykode announces that Michael Engsig, CEO, Agnete Fredriksen, CSO & Co-founder, and Harald Gurvin, CFO, have withdrawn their recent resignations and will continue with Nykode.
In a new job - April 10, 2025
Gesynta Pharma appoints new CMO/VP Clinical Development
Eva Johnsson brings experience in clinical drug development and medical affairs, including regulatory approvals and drug commercialization.
In a new job - April 9, 2025
She is the new CEO of Valo Therapeutics
Marcella Origgi has been appointed Chief Executive Officer (CEO) of the company's Helsinki headquarters and Naples subsidiary.
